Open AccessSuppression of Ventricular Tachycardia Associated with Cardiac Sarcoidosis by Steroid Therapy
Author(s) -
Miyaji Kotaro,
Suzuki Makoto,
Mizukami Akira,
Iwatsuka Ryota,
Kumasaka Reon,
Ichihara Naoaki,
Nagahori Wataru,
Oono Masakazu,
Arakawa Tetsuo,
Masaki Nobuyuki,
Matsumura Akihiko,
Hashimoto Yuji
Publication year - 2007
Publication title -
journal of arrhythmia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 21
eISSN - 1883-2148
pISSN - 1880-4276
DOI - 10.1016/s1880-4276(07)80036-6
Subject(s) - medicine , cardiac sarcoidosis , cardiology , atrioventricular block , amiodarone , sarcoidosis , ventricular fibrillation , ventricular tachycardia , refractory (planetary science) , implantable cardioverter defibrillator , atrial fibrillation , physics , astrobiology
In patients with cardiac sarcoidosis, ventricular tachycardia (VT) is observed in some cases. However, effective therapies for the VT are still unknown. Case: A 50‐year old female with cardiac sarcoidosis underwent DDD pacemaker implantation for a high degree atrioventricular block with symptoms of faintness and shortness of breath. One month after the surgery, she was admitted for frequent episodes of non‐sustained VT. In the electrophysiologic study (EPS), sustained monomorphic VT and ventricular fibrillation were induced; therefore pacemaker was replaced with implantable cardioverter‐defibrillator (ICD). Amiodarone was started orally but it couldn't suppress frequent VT episodes, and frequent ICD shocks were delivered. When the oral steroid therapy was initiated for the cardiac sarcoidosis, it not only suppressed the frequent VT but also improved the atrioventricular nodal dysfunction. In conclusion, steroid therapy might be an option to consider in cardiac sarcoidosis with refractory VT.